NovaBridge Biosciences (NBP) Assets Average (2020 - 2025)

NovaBridge Biosciences (NBP) has 6 years of Assets Average data on file, last reported at $269.0 million in Q4 2025.

• Assets Average for Q4 2025 came in at $269.0 million, up 20.79% year-over-year; the trailing twelve-month figure through Dec 2025 was $269.0 million (up 20.79% YoY), and the FY2025 annual result was $236.6 million, down 18.66% from the prior year.
• Assets Average grew to $269.0 million in Q4 2025 per NBP's latest filing, from $242.1 million in the prior quarter.
• Over five years, Assets Average peaked at $954.0 million in Q2 2021 and troughed at $207.8 million in Q2 2025.
• A 5-year average of $478.4 million and a median of $269.0 million in 2025 frame the typical range for Assets Average.
• The sharpest annual moves came in 2021 and 2023: Assets Average soared 255.62% in 2021, then sank 34.8% in 2023.
• A 5-year view of Assets Average shows it stood at $914.1 million in 2021, then retreated by 27.91% to $659.0 million in 2022, then decreased by 19.8% to $528.5 million in 2023, then sank by 57.87% to $222.7 million in 2024, then grew by 20.79% to $269.0 million in 2025.
• Business Quant data shows NBP's Assets Average at $269.0 million in Q4 2025, $242.1 million in Q3 2025, and $207.8 million in Q2 2025.